These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 18237792)

  • 41. Prognostic importance of increased plasma amino-terminal pro-brain natriuretic peptide levels in a large noncardiac, general intensive care unit population.
    Kotanidou A; Karsaliakos P; Tzanela M; Mavrou I; Kopterides P; Papadomichelakis E; Theodorakopoulou M; Botoula E; Tsangaris I; Lignos M; Ikonomidis I; Ilias I; Armaganidis A; Orfanos SE; Dimopoulou I
    Shock; 2009 Apr; 31(4):342-7. PubMed ID: 18791494
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic value of brain natriuretic peptide in noncardiac surgery: a meta-analysis.
    Ryding AD; Kumar S; Worthington AM; Burgess D
    Anesthesiology; 2009 Aug; 111(2):311-9. PubMed ID: 19602961
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of N-terminal pro-brain natriuretic peptide and cystatin C to estimate renal function in patients with and without heart failure.
    Linzbach S; Samigullin A; Yilmaz S; Tsioga M; Zeiher AM; Spyridopoulos I
    Am J Cardiol; 2009 Apr; 103(8):1128-33. PubMed ID: 19361601
    [TBL] [Abstract][Full Text] [Related]  

  • 44. B-type natriuretic peptide: a strong predictor of early and late mortality in patients with acute chest pain without ST-segment elevation in the emergency department.
    Bassan R; Tura BR; Maisel AS
    Coron Artery Dis; 2009 Mar; 20(2):143-9. PubMed ID: 19293713
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic value of cardiac biomarkers for death in a non-dialysis chronic kidney disease population.
    Vickery S; Webb MC; Price CP; John RI; Abbas NA; Lamb EJ
    Nephrol Dial Transplant; 2008 Nov; 23(11):3546-53. PubMed ID: 18562472
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
    J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
    [TBL] [Abstract][Full Text] [Related]  

  • 47. N-Terminal pro B-type natriuretic peptide testing for short-term prognosis in breathless older adults.
    Chenevier-Gobeaux C; Allo JC; Arthaud M; Achkar R; Claessens YE; Ekindjian OG; Riou B; Ray P
    Am J Emerg Med; 2008 Jun; 26(5):555-60. PubMed ID: 18534284
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Decrease of plasma N-terminal pro beta-type natriuretic peptide as a predictor of clinical improvement after cardiac resynchronization therapy for heart failure.
    Ding LG; Hua W; Zhang S; Chu JM; Chen KP; Wang Y; Wang FZ; Chen X
    Chin Med J (Engl); 2009 Mar; 122(6):617-21. PubMed ID: 19323922
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasma B-type natriuretic peptide predicts atrial fibrillation during rehabilitation after cardiac surgery.
    Sarzi Braga S; Vaninetti R; Pedretti RF
    Eur J Cardiovasc Prev Rehabil; 2008 Aug; 15(4):460-6. PubMed ID: 18677172
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome.
    Narain VS; Gupta N; Sethi R; Puri A; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2008; 60(6):536-42. PubMed ID: 19276492
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The predictive value of plasma brain natriuretic peptide for the recurrence of atrial fibrillation six months after external cardioversion.
    Ari H; Binici S; Ari S; Akkaya M; Koca V; Bozat T; Gürdoğan M
    Turk Kardiyol Dern Ars; 2008 Oct; 36(7):456-60. PubMed ID: 19155659
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiac biomarkers and exercise duration and intensity during a cycle-touring event.
    Serrano-Ostáriz E; Legaz-Arrese A; Terreros-Blanco JL; López-Ramón M; Cremades-Arroyos D; Carranza-García LE; Izquierdo-Alvarez S; Bocos-Terraz P
    Clin J Sport Med; 2009 Jul; 19(4):293-9. PubMed ID: 19638823
    [TBL] [Abstract][Full Text] [Related]  

  • 53. N-terminal-pro-brain natriuretic peptide for the differential diagnosis of hypovolemia vs. euvolemia in hyponatremic patients.
    Bunnag S; Pattanasombatsakul K
    J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S69-74. PubMed ID: 22619890
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Signification of NT-proBNP in the differential diagnosis of syncope in adults].
    Stryjewski PJ; Kuczaj A; Badacz L; Opara M; Nowalany-Kozielska E; Nowak J; Nessler J
    Przegl Lek; 2014; 71(5):249-53. PubMed ID: 25248238
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of exercise capacity with cardiopulmonary exercise test and B-type natriuretic peptide in adults with congenital heart disease.
    Trojnarska O; Gwizdała A; Katarzyński S; Katarzyńska A; Szyszka A; Lanocha M; Grajek S; Kramer L
    Cardiol J; 2009; 16(2):133-41. PubMed ID: 19387960
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Brain natriuretic peptide testing for angina in a rapid-access chest pain clinic.
    Connolly SB; Collier T; Khugputh R; Tataree D; Kyereme K; Merritt S; Struthers AD; Fox KF
    QJM; 2007 Dec; 100(12):779-83. PubMed ID: 17965439
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma NT-proBNP levels and the risk of atrial fibrillation after major lung resection.
    Gurgo AM; Ciccone AM; D'Andrilli A; Ibrahim M; Musumeci B; Quarta G; Saponaro A; Rendina EA; Volpe M
    Minerva Cardioangiol; 2008 Dec; 56(6):581-5. PubMed ID: 19092733
    [TBL] [Abstract][Full Text] [Related]  

  • 58. NT-pro-BNP: not the prognostic all-rounder in elderly patients undergoing allogeneic stem cell transplantation.
    Haas PS; Ihorst G; Schnitzler S; Wäsch R; Marks R; Bertz H; Mertelsmann R; Finke J; Deschler B
    Ann Hematol; 2012 Dec; 91(12):1929-35. PubMed ID: 22847152
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Significance of plasma levels of N-terminal Pro-B-type natriuretic peptide on left ventricular remodeling in non-obstructive hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene.
    Magga J; Sipola P; Vuolteenaho O; Risteli J; Jääskeläinen P; Peuhkurinen K; Kuusisto J
    Am J Cardiol; 2008 Apr; 101(8):1185-90. PubMed ID: 18394456
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The additive value of N-terminal pro-B-type natriuretic peptide testing at the emergency department in patients with acute dyspnoea.
    van der Burg-de Graauw N; Cobbaert CM; Middelhoff CJ; Bantje TA; van Guldener C
    Eur J Intern Med; 2009 May; 20(3):301-6. PubMed ID: 19393498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.